
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei, et al.
The Lancet (2021) Vol. 398, Iss. 10304, pp. 957-980
Open Access | Times Cited: 2415
Bin Zhou, Rodrigo M. Carrillo‐Larco, Goodarz Danaei, et al.
The Lancet (2021) Vol. 398, Iss. 10304, pp. 957-980
Open Access | Times Cited: 2415
Showing 1-25 of 2415 citing articles:
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1452
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults
Nowell H Phelps, Rosie Singleton, Bin Zhou, et al.
The Lancet (2024) Vol. 403, Iss. 10431, pp. 1027-1050
Open Access | Times Cited: 567
Nowell H Phelps, Rosie Singleton, Bin Zhou, et al.
The Lancet (2024) Vol. 403, Iss. 10431, pp. 1027-1050
Open Access | Times Cited: 567
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Michael Bräuer, Gregory A. Roth, Aleksandr Y. Aravkin, et al.
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2162-2203
Open Access | Times Cited: 518
Michael Bräuer, Gregory A. Roth, Aleksandr Y. Aravkin, et al.
The Lancet (2024) Vol. 403, Iss. 10440, pp. 2162-2203
Open Access | Times Cited: 518
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Kunihiro Matsushita, Shoshana H. Ballew, Angela Yee‐Moon Wang, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 696-707
Closed Access | Times Cited: 314
Kunihiro Matsushita, Shoshana H. Ballew, Angela Yee‐Moon Wang, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 696-707
Closed Access | Times Cited: 314
Health and related indicators 2021
Noluthando Ndlovu, Andy Gray, Bonga Mkhabela, et al.
South African Health Review (2022) Vol. 24
Open Access | Times Cited: 265
Noluthando Ndlovu, Andy Gray, Bonga Mkhabela, et al.
South African Health Review (2022) Vol. 24
Open Access | Times Cited: 265
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
Valery L. Feigin, Mayowa Owolabi, Valery L. Feigin, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 12, pp. 1160-1206
Open Access | Times Cited: 188
Valery L. Feigin, Mayowa Owolabi, Valery L. Feigin, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 12, pp. 1160-1206
Open Access | Times Cited: 188
Projected Global Trends in Ischemic Stroke Incidence, Deaths and Disability-Adjusted Life Years From 2020 to 2030
Liyuan Pu, Li Wang, Ruijie Zhang, et al.
Stroke (2023) Vol. 54, Iss. 5, pp. 1330-1339
Open Access | Times Cited: 181
Liyuan Pu, Li Wang, Ruijie Zhang, et al.
Stroke (2023) Vol. 54, Iss. 5, pp. 1330-1339
Open Access | Times Cited: 181
Primary stroke prevention worldwide: translating evidence into action
Mayowa Owolabi, Amanda G. Thrift, Ajay Mahal, et al.
The Lancet Public Health (2021) Vol. 7, Iss. 1, pp. e74-e85
Open Access | Times Cited: 159
Mayowa Owolabi, Amanda G. Thrift, Ajay Mahal, et al.
The Lancet Public Health (2021) Vol. 7, Iss. 1, pp. e74-e85
Open Access | Times Cited: 159
Sex differences in arterial hypertension
Eva Gerdts, Isabella Sudano, Sofie Brouwers, et al.
European Heart Journal (2022) Vol. 43, Iss. 46, pp. 4777-4788
Open Access | Times Cited: 139
Eva Gerdts, Isabella Sudano, Sofie Brouwers, et al.
European Heart Journal (2022) Vol. 43, Iss. 46, pp. 4777-4788
Open Access | Times Cited: 139
Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey
Mei Zhang, Yu Shi, Bin Zhou, et al.
BMJ (2023), pp. e071952-e071952
Open Access | Times Cited: 132
Mei Zhang, Yu Shi, Bin Zhou, et al.
BMJ (2023), pp. e071952-e071952
Open Access | Times Cited: 132
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Markus P. Schlaich, M Bellet, Michael A. Weber, et al.
The Lancet (2022) Vol. 400, Iss. 10367, pp. 1927-1937
Open Access | Times Cited: 130
Markus P. Schlaich, M Bellet, Michael A. Weber, et al.
The Lancet (2022) Vol. 400, Iss. 10367, pp. 1927-1937
Open Access | Times Cited: 130
Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease
Michel Burnier, Aikaterini Damianaki
Circulation Research (2023) Vol. 132, Iss. 8, pp. 1050-1063
Closed Access | Times Cited: 129
Michel Burnier, Aikaterini Damianaki
Circulation Research (2023) Vol. 132, Iss. 8, pp. 1050-1063
Closed Access | Times Cited: 129
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries
David Watkins, William Msemburi, Sarah Pickersgill, et al.
The Lancet (2022) Vol. 399, Iss. 10331, pp. 1266-1278
Open Access | Times Cited: 128
David Watkins, William Msemburi, Sarah Pickersgill, et al.
The Lancet (2022) Vol. 399, Iss. 10331, pp. 1266-1278
Open Access | Times Cited: 128
The gut microbiome and hypertension
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 127
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 127
Endovascular Ultrasound Renal Denervation to Treat Hypertension
Michel Azizi, Manish Saxena, Yale Wang, et al.
JAMA (2023) Vol. 329, Iss. 8, pp. 651-651
Open Access | Times Cited: 111
Michel Azizi, Manish Saxena, Yale Wang, et al.
JAMA (2023) Vol. 329, Iss. 8, pp. 651-651
Open Access | Times Cited: 111
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Emanuele Barbato, Michel Azizi, Roland E. Schmieder, et al.
European Heart Journal (2023) Vol. 44, Iss. 15, pp. 1313-1330
Open Access | Times Cited: 105
Emanuele Barbato, Michel Azizi, Roland E. Schmieder, et al.
European Heart Journal (2023) Vol. 44, Iss. 15, pp. 1313-1330
Open Access | Times Cited: 105
Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease
Zhan Zhang, Rinkoo Dalan, Zhenyu Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 35
Open Access | Times Cited: 101
Zhan Zhang, Rinkoo Dalan, Zhenyu Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 35
Open Access | Times Cited: 101
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 99
Jun Ma, Yanan Li, Xiangyu Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 99
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial
Yingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
The Lancet (2022) Vol. 399, Iss. 10339, pp. 1964-1975
Closed Access | Times Cited: 94
Yingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
The Lancet (2022) Vol. 399, Iss. 10339, pp. 1964-1975
Closed Access | Times Cited: 94
Hypertension management in patients with cardiovascular comorbidities
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 94
Lucas Lauder, Felix Mahfoud, Michel Azizi, et al.
European Heart Journal (2022) Vol. 44, Iss. 23, pp. 2066-2077
Open Access | Times Cited: 94
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 93
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 93
Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events
Areef Ishani, William C. Cushman, Sarah Leatherman, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 26, pp. 2401-2410
Open Access | Times Cited: 89
Areef Ishani, William C. Cushman, Sarah Leatherman, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 26, pp. 2401-2410
Open Access | Times Cited: 89
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
Fadi J. Charchar, Priscilla R. Prestes, Charlotte Mills, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 1, pp. 23-49
Open Access | Times Cited: 86
Fadi J. Charchar, Priscilla R. Prestes, Charlotte Mills, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 1, pp. 23-49
Open Access | Times Cited: 86
Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association
Jordana B. Cohen, Nancy J. Brown, Sherry‐Ann Brown, et al.
Hypertension (2023) Vol. 80, Iss. 3
Open Access | Times Cited: 85
Jordana B. Cohen, Nancy J. Brown, Sherry‐Ann Brown, et al.
Hypertension (2023) Vol. 80, Iss. 3
Open Access | Times Cited: 85
Hypertension in China: epidemiology and treatment initiatives
Ji‐Guang Wang, Ying Zhang, Yan Li, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 8, pp. 531-545
Closed Access | Times Cited: 85
Ji‐Guang Wang, Ying Zhang, Yan Li, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 8, pp. 531-545
Closed Access | Times Cited: 85